Brief: Diasorin Obtained FDA Approval For Fully Automated Laboratory Serology Tests For Human Parvovirus B19 Igm And Human Parvovirus B19 Igg On The Liaison Xl
13/10/2026 12:05
BRIEF-Diasorin Obtained FDA Approval For Fully Automated Laboratory Serology Tests For Human Parvovirus B19 Igm And Human Parvovirus B19 Igg On The Liaison Xl Oct 13 (Reuters) - Diasorin S.p.A. DIAS.MI:
OBTAINED FDA APPROVAL FOR THE FIRST FULLY AUTOMATED LABORATORY SEROLOGY TESTS FOR HUMAN PARVOVIRUS B19 IGM AND HUMAN PARVOVIRUS B19 IGG ON THE LIAISON XL
Further company coverage: DIAS.MI
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Diasorin
See all newsEquita upgrades Diasorin, sees 'solid' Q3
Brief: Diasorin Obtained FDA Approval For Fully Automated Laboratory Serology Tests For Human Parvovirus B19 Igm And Human Parvovirus B19 Igg On The Liaison Xl
Europe Research Roundup: Allianz, Mercedes-Benz, Tesco
European life sciences stocks rise on strong sector momentum
Italy - Factors to watch on September 21